- Home
- KURA vs SNDL Comparison
KURA vs SNDL Comparison
Compare KURA & SNDL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KURA
- SNDL
- Stock Information
- Founded
- KURA 2014
- SNDL 2006
- Country
- KURA United States
- SNDL Canada
- Employees
- KURA N/A
- SNDL N/A
- Industry
- KURA Biotechnology: Biological Products (No Diagnostic Substances)
- SNDL Pharmaceuticals and Biotechnology
- Sector
- KURA Health Care
- SNDL Health Care
- Exchange
- KURA Nasdaq
- SNDL Nasdaq
- Market Cap
- KURA 713.5M
- SNDL 643.4M
- IPO Year
- KURA N/A
- SNDL 2019
- Fundamental
- Price
- KURA $8.09
- SNDL $2.50
- Analyst Decision
- KURA Buy
- SNDL Strong Buy
- Analyst Count
- KURA 14
- SNDL 1
- Target Price
- KURA $24.45
- SNDL $5.00
- AVG Volume (30 Days)
- KURA 1.7M
- SNDL 3.5M
- Earning Date
- KURA 11-06-2025
- SNDL 11-04-2025
- Dividend Yield
- KURA N/A
- SNDL N/A
- EPS Growth
- KURA N/A
- SNDL N/A
- EPS
- KURA N/A
- SNDL N/A
- Revenue
- KURA $83,279,000.00
- SNDL $692,339,389.00
- Revenue This Year
- KURA $60.25
- SNDL $5.30
- Revenue Next Year
- KURA $155.10
- SNDL $4.11
- P/E Ratio
- KURA N/A
- SNDL N/A
- Revenue Growth
- KURA N/A
- SNDL 3.54
- 52 Week Low
- KURA $5.41
- SNDL $1.15
- 52 Week High
- KURA $21.40
- SNDL $2.74
- Technical
- Relative Strength Index (RSI)
- KURA 55.99
- SNDL 63.38
- Support Level
- KURA $8.09
- SNDL $2.36
- Resistance Level
- KURA $8.90
- SNDL $2.54
- Average True Range (ATR)
- KURA 0.51
- SNDL 0.12
- MACD
- KURA -0.05
- SNDL -0.03
- Stochastic Oscillator
- KURA 35.20
- SNDL 41.46
About KURA Kura Oncology Inc.
Kura Oncology Inc is a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer. The company's pipeline consists of small molecule drug candidates targeting cancer signaling pathways.
About SNDL SNDL Inc.
SNDL Inc is a private-sector liquor and cannabis retailer in Canada with retail banners that include Ace Liquor, Wine and Beyond, Liquor Depot, Value Buds, and Spiritleaf. The principal activities of the company are the retailing of wines, beers, and spirits. It comprised four reportable segments: liquor retail, cannabis retail, cannabis operations, and investments. Liquor retail includes the sale of wines, beers, and spirits through owned liquor stores. The company generates maximum revenue from liquor retail.